Meacham syndrome
| Meacham syndrome | |
|---|---|
| Synonyms | Meacham syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Congenital heart defects, ambiguous genitalia, diaphragmatic hernia |
| Complications | Respiratory distress, cardiac complications |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Fraser syndrome, Denys-Drash syndrome |
| Prevention | N/A |
| Treatment | Surgical intervention, supportive care |
| Medication | N/A |
| Prognosis | Variable, depends on severity of symptoms |
| Frequency | Rare |
| Deaths | N/A |
Meacham Syndrome is a rare congenital disorder characterized by a combination of pulmonary hypoplasia, congenital diaphragmatic hernia, cardiac malformations, and genitourinary abnormalities. It was first described by Meacham et al. in 1981.
Etiology[edit]
The exact cause of Meacham Syndrome is currently unknown. However, it is believed to be a genetic disorder, possibly inherited in an autosomal recessive manner.
Clinical Features[edit]
The clinical features of Meacham Syndrome can vary greatly among affected individuals. However, the four primary features are:
- Pulmonary Hypoplasia: This is a condition in which the lungs are underdeveloped. This can lead to respiratory distress and other breathing problems.
- Congenital Diaphragmatic Hernia: This is a condition in which there is a hole in the diaphragm, allowing the abdominal organs to move into the chest cavity. This can further exacerbate the pulmonary hypoplasia.
- Cardiac Malformations: These can include a variety of heart defects, such as ventricular septal defect (VSD), atrial septal defect (ASD), and patent ductus arteriosus (PDA).
- Genitourinary Abnormalities: These can include a variety of abnormalities of the genitalia and urinary system, such as cryptorchidism, hypospadias, and renal agenesis.
Diagnosis[edit]
Diagnosis of Meacham Syndrome is typically based on the presence of the characteristic clinical features. Genetic testing may also be performed to confirm the diagnosis and identify the specific genetic mutation.
Treatment[edit]
Treatment of Meacham Syndrome is typically supportive and depends on the specific symptoms present. This can include respiratory support for pulmonary hypoplasia, surgical repair of the diaphragmatic hernia, and management of cardiac and genitourinary abnormalities.
Prognosis[edit]
The prognosis for individuals with Meacham Syndrome is generally poor, due to the severity of the associated abnormalities. However, with appropriate treatment and management, some individuals may survive into adulthood.
See Also[edit]
- Congenital Diaphragmatic Hernia
- Pulmonary Hypoplasia
- Cardiac Malformations
- Genitourinary Abnormalities
NIH genetic and rare disease info[edit]
Meacham syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Meacham syndrome
|
| Congenital Disorders | ||||||||
|---|---|---|---|---|---|---|---|---|
This congenital disorder related article is a stub.
|
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Syndromes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This syndrome related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
